These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27569899)

  • 21. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S; Setterfield J; Black MM
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroxychloroquine myopathy.
    Richards AJ
    J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P
    Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI).
    Yokogawa N; Tanikawa A; Amagai M; Kato Y; Momose Y; Arai S; Eto H; Ikeda T; Furukawa F
    Mod Rheumatol; 2013 Mar; 23(2):318-22. PubMed ID: 22581095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating results of an interferon-γ release assay in patients with autoimmune disease who are taking hydroxychloroquine.
    Gaffney RG; Werth VP
    J Am Acad Dermatol; 2019 Apr; 80(4):1162-1164. PubMed ID: 30582995
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
    Endo Y; Koga T; Umeda M; Furukawa K; Sasaki D; Yanagihara K; Kawakami A
    Rheumatology (Oxford); 2020 Apr; 59(4):903-905. PubMed ID: 31580461
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxychloroquine and lupus flare: a good drug, but we need to do better.
    Crow MK; Kirou KA
    Ann Rheum Dis; 2022 Mar; 81(3):303-305. PubMed ID: 35039325
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama: a pilot study.
    Ikeda T; Kanazawa N; Furukawa F
    J Dermatol; 2012 Jun; 39(6):531-5. PubMed ID: 22168306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al.
    Costedoat-Chalumeau N; Amoura Z; Marra D; Piette JC
    Arthritis Rheum; 2008 Jan; 59(1):153; author reply 153-4. PubMed ID: 18163410
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of hydroxychloroquine on lupus erythematosus-like skin lesions in MRL/lpr mice.
    Shimomatsu T; Kanazawa N; Mikita N; Nakatani Y; Li HJ; Inaba Y; Ikeda T; Kondo T; Furukawa F
    Mod Rheumatol; 2016 Sep; 26(5):744-8. PubMed ID: 26873035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
    Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
    J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
    Mendel A; Bernatsky S; Askanase A; Bae SC; Clarke AE; Costedoat-Chalumeau N; Gladman DD; Gordon C; Hanly J; Jacobsen S; Kalunian K; Mak A; Mosca M; Pons-Estel BA; Ruiz-Irastorza G; Urowitz M; Vinet É
    Ann Rheum Dis; 2021 Feb; 80(2):1-2. PubMed ID: 32586918
    [No Abstract]   [Full Text] [Related]  

  • 33. Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.
    Tincopa M; Puttgen KB; Sule S; Cohen BA; Gerstenblith MR
    Pediatr Dermatol; 2010; 27(4):373-6. PubMed ID: 20653856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
    Chiang E; Jampol LM; Fawzi AA
    Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous manifestations of connective tissue disease.
    McCammack E; Haggstrom AN
    Adolesc Med State Art Rev; 2011 Apr; 22(1):35-53. PubMed ID: 21815443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
    Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
    Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction.
    Takezawa K; Ueda-Hayakawa I; Yamazaki F; Kambe N; Son Y; Okamoto H
    Lupus; 2020 Jan; 29(1):79-82. PubMed ID: 31789124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.
    Petri M
    Lupus; 1996 Jun; 5 Suppl 1():S16-22. PubMed ID: 8803905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.